← All trials
NCT04441047
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 6, 2021
- Primary completion
- Jul 7, 2021
- Completion date
- Dec 31, 2021
- First posted
- Jun 22, 2020
- Last posted
- Nov 20, 2020
- Enrollment
- 40
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Immunovative TherapiesLead sponsor
- Mirror PharmsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.